47 results on '"Koss C"'
Search Results
2. The Anti-Fibrotic Drug Nintedanib Promotes Repair Macrophages
- Author
-
Koss, C, primary, Fundel-Clemens, K, additional, Schlösser, D, additional, Lerner, C, additional, Frey, S, additional, Wohnhaas, C T, additional, Viollet, C, additional, Dichtl, S, additional, Tilp, C, additional, Thomas, M J, additional, Gantner, F, additional, Skronska-Wasek, W, additional, Huber, H J, additional, Murray, P J, additional, Ramirez, F, additional, and El Kasmi, K C, additional
- Published
- 2021
- Full Text
- View/download PDF
3. GENDER COMPARISONS OF PHYSIOLOGIC AND PERCEPTUAL RESPONSES TO A 1-HOUR RUN AT MARATHON PACE
- Author
-
Loftin, M, Sothern, M, Koss, C, Kontos, A, Tuuri, G, and VanVrancken, C
- Published
- 2003
4. COMPARISON OF INDIVIDUALS WITH SIGNIFICANT MENTAL DISABILITIES AND THEIR TYPICAL PEERS VIA HEART RATE MONITORING
- Author
-
Koss, C and Loftin, M
- Published
- 2001
5. ENERGY EXPENDITURE AND INFLUENCE OF PHYSIOLOGIC FACTORS DURING MARATHON RUNNING
- Author
-
Loftin, M, Sothern, M, and Koss, C
- Published
- 2001
6. ENCOUNTERS WITH DIFFERENT TYPES OF HEALTH CARE PROVIDERS AND ADVANCE DIRECTIVE COMPLETION
- Author
-
Koss, C, primary
- Published
- 2018
- Full Text
- View/download PDF
7. GOING IT ALONE: SPOUSAL HETEROGAMY AND ADVANCE DIRECTIVE DISCORDANCE IN OLDER MARRIED COUPLES
- Author
-
Koss, C, primary and Jensen, D, additional
- Published
- 2018
- Full Text
- View/download PDF
8. Pediatric non–Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes
- Author
-
Rooij, J.D. (Johan) de, Branstetter, C. (Cristyn), Ma, J. (Jing), Li, Y. (Yongjin), Walsh, M.P. (Michael P), Cheng, J. (Jinjun), Obulkasim, A. (Askar), Dang, J. (Jinjun), Easton, J. (John), Verboon, P. (Peter), Mulder, H.L. (Heather L), Zimmermann, M. (Martin), Koss, C. (Cary), Gupta, P. (Pankaj), Edmonson, M. (Michael), Rusch, M. (Michael), Lim, J.Y.S. (Joshua Yew Suang), Reinhardt, K. (Katarina), Pigazzi, M. (Martina), Song, G. (Guangchun), Yeoh, A.E.J. (Allen E. J.), Shih, L.-Y. (Lee-Yung), Liang, D. (Der), Halene, S. (Stephanie), Krause, D.S. (Diane S), Zhang, J. (Jinghui), Downing, J.R. (James), Locatelli, F. (Franco), Reinhardt, D. (Dirk), Heuvel-Eibrink, M.M. (Marry) van den, Zwaan, C.M. (Michel), Fornerod, M.W.J. (Maarten), Gruber, T.A. (Tanja A), Rooij, J.D. (Johan) de, Branstetter, C. (Cristyn), Ma, J. (Jing), Li, Y. (Yongjin), Walsh, M.P. (Michael P), Cheng, J. (Jinjun), Obulkasim, A. (Askar), Dang, J. (Jinjun), Easton, J. (John), Verboon, P. (Peter), Mulder, H.L. (Heather L), Zimmermann, M. (Martin), Koss, C. (Cary), Gupta, P. (Pankaj), Edmonson, M. (Michael), Rusch, M. (Michael), Lim, J.Y.S. (Joshua Yew Suang), Reinhardt, K. (Katarina), Pigazzi, M. (Martina), Song, G. (Guangchun), Yeoh, A.E.J. (Allen E. J.), Shih, L.-Y. (Lee-Yung), Liang, D. (Der), Halene, S. (Stephanie), Krause, D.S. (Diane S), Zhang, J. (Jinghui), Downing, J.R. (James), Locatelli, F. (Franco), Reinhardt, D. (Dirk), Heuvel-Eibrink, M.M. (Marry) van den, Zwaan, C.M. (Michel), Fornerod, M.W.J. (Maarten), and Gruber, T.A. (Tanja A)
- Abstract
Acute megakaryoblastic leukemia (AMKL) is a subtype of acute myeloid leukemia (AML) in which cells morphologically resemble abnormal megakaryoblasts. While rare in adults, AMKL accounts for 4–15% of newly diagnosed childhood AML cases. AMKL in individuals without Down syndrome (non-DS-AMKL) is frequently associated with poor clinical outcomes. Previous efforts have identified chimeric oncogenes in a substantial number of
- Published
- 2017
- Full Text
- View/download PDF
9. Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes
- Author
-
De Rooij, J. D. E., Branstetter, C., Ma, J., Li, Y., Walsh, M. P., Cheng, J., Obulkasim, A., Dang, J., Easton, J., Verboon, L. J., Mulder, H. L., Zimmermann, M., Koss, C., Gupta, P., Edmonson, M., Rusch, M., Lim, J. Y. S., Reinhardt, K., Pigazzi, M., Song, G., Yeoh, A. E. J., Shih, L. -Y., Liang, D. -C., Halene, S., Krause, D. S., Zhang, J., Downing, J. R., Locatelli, Franco, Reinhardt, D., Van Den Heuvel-Eibrink, M. M., Zwaan, C. M., Fornerod, M., Gruber, T. A., Locatelli F. (ORCID:0000-0002-7976-3654), De Rooij, J. D. E., Branstetter, C., Ma, J., Li, Y., Walsh, M. P., Cheng, J., Obulkasim, A., Dang, J., Easton, J., Verboon, L. J., Mulder, H. L., Zimmermann, M., Koss, C., Gupta, P., Edmonson, M., Rusch, M., Lim, J. Y. S., Reinhardt, K., Pigazzi, M., Song, G., Yeoh, A. E. J., Shih, L. -Y., Liang, D. -C., Halene, S., Krause, D. S., Zhang, J., Downing, J. R., Locatelli, Franco, Reinhardt, D., Van Den Heuvel-Eibrink, M. M., Zwaan, C. M., Fornerod, M., Gruber, T. A., and Locatelli F. (ORCID:0000-0002-7976-3654)
- Abstract
Acute megakaryoblastic leukemia (AMKL) is a subtype of acute myeloid leukemia (AML) in which cells morphologically resemble abnormal megakaryoblasts. While rare in adults, AMKL accounts for 4-15% of newly diagnosed childhood AML cases. AMKL in individuals without Down syndrome (non-DS-AMKL) is frequently associated with poor clinical outcomes. Previous efforts have identified chimeric oncogenes in a substantial number of non-DS-AMKL cases, including RBM15-MKL1, CBFA2T3-GLIS2, KMT2A gene rearrangements, and NUP98-KDM5A. However, the etiology of 30-40% of cases remains unknown. To better understand the genomic landscape of non-DS-AMKL, we performed RNA and exome sequencing on specimens from 99 patients (75 pediatric and 24 adult). We demonstrate that pediatric non-DS-AMKL is a heterogeneous malignancy that can be divided into seven subgroups with varying outcomes. These subgroups are characterized by chimeric oncogenes with cooperating mutations in epigenetic and kinase signaling genes. Overall, these data shed light on the etiology of AMKL and provide useful information for the tailoring of treatment.
- Published
- 2017
10. SPOUSAL INFLUENCES ON ADVANCE DIRECTIVE COMPLETION
- Author
-
Koss, C., primary
- Published
- 2017
- Full Text
- View/download PDF
11. RELIGIOSITY AND ADVANCE CARE PLANNING BY WHITE AND AFRICAN AMERICAN OLDER ADULTS
- Author
-
Koss, C., primary
- Published
- 2017
- Full Text
- View/download PDF
12. Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus
- Author
-
Palles, C. (Claire), Chegwidden, L. (Laura), Li, X. (Xinzhong), Findlay, J.M. (John M.), Farnham, G. (Garry), Castro Giner, F. (Francesc), Peppelenbosch, M.P. (Maikel), Kovac, M. (Michal), Adams, C.L. (Claire), Prenen, H. (Hans), Briggs, S. (Sarah), Harrison, R. (Rebecca), Sanders, S. (Scott), Macdonald, D.R.W. (David), Haigh, K. (Katharina), Tucker, A.T. (Art), Love, S. (Sharon), Nanji, M. (Manoj), Decaestecker, J. (John), Ferry, D.R. (David), Rathbone, B. (Barrie), Hapeshi, J. (Julie), Barr, H. (Hugh), Moayyedi, P. (Paul), Watson, P. (Peter), Zietek, B. (Barbara), Maroo, N. (Neera), Gay, L. (Laura), Underwood, T. (Tim), Boulter, L. (Lisa), McMurtry, H. (Hugh), Monk, A.B. (Alastair), Patel, P. (Poulam), Ragunath, K. (Krish), Al Dulaimi, D. (David), Murray, I. (Iain), Koss, C. (Clara), Veitch, A. (Andrew), Trudgill, N. (Nigel), Nwokolo, C. (Chuka), Rembacken, B., Atherfold, P. (Paul), Green, E.K. (Elaine K), Ang, Y. (Yeng), Kuipers, E.J. (Ernst), Chow, W. (Wu), Paterson, S. (Stuart), Kadri, S. (Sudarshan), Beales, I. (Ian), Grimley, C. (Charles), Mullins, P. (Paul), Beckett, C. (Conrad), Farrant, M. (Mark), Dixon, A. (Andrew), Kelly, S. (Sean), Johnson, M. (Matthew), Wajed, S. (Shahjehan), Dhar, A. (Archana), Sawyer, E.J. (Elinor), Roylance, R. (Rebecca), Onstad, L. (Lynn), Gammon, M.D. (Marilie), Corley, D.A. (Douglas), Shaheen, N. (Nazima), Bird, N.C. (Nigel), Hardie, B.G.S. (Bruce), Reid, B.J. (Brian), Ye, W. (Weimin), Liu, G. (Geoffrey), Romero, Y. (Yvonne), Bernstein, L. (Leslie), Wu, A.H. (Anna H.), Casson, A.G. (Alan), Fitzgerald, R.C. (Rebecca), Whiteman, D.C. (David C.), Risch, H. (Harvey), Levine, D.M. (David M.), Vaughan, T.L. (Thomas), Verhaar, A.P. (Auke), Van Den Brande, J. (Jan), Toxopeus, E.L.A. (Eelke), Spaander, M.C.W. (Manon), Wijnhoven, B.P.L. (Bas), Laan, L.J.W. (Luc) van der, Krishnadath, K.K. (Kausilia), Wijmenga, C. (Cisca), Trynka, G. (Gosia), McManus, R. (Ross), Reynolds, J.V. (John V.), O'Sullivan, J. (Jacintha), Macmathuna, P. (Padraic), McGarrigle, S.A. (Sarah A.), Kelleher, D. (Dermot), Vermeire, S. (Séverine), Cleynen, I. (Isabelle), Bisschops, R. (Raf), Tomlinson, I.P. (Ian), Jankowski, J.A. (Janusz Antoni), Palles, C. (Claire), Chegwidden, L. (Laura), Li, X. (Xinzhong), Findlay, J.M. (John M.), Farnham, G. (Garry), Castro Giner, F. (Francesc), Peppelenbosch, M.P. (Maikel), Kovac, M. (Michal), Adams, C.L. (Claire), Prenen, H. (Hans), Briggs, S. (Sarah), Harrison, R. (Rebecca), Sanders, S. (Scott), Macdonald, D.R.W. (David), Haigh, K. (Katharina), Tucker, A.T. (Art), Love, S. (Sharon), Nanji, M. (Manoj), Decaestecker, J. (John), Ferry, D.R. (David), Rathbone, B. (Barrie), Hapeshi, J. (Julie), Barr, H. (Hugh), Moayyedi, P. (Paul), Watson, P. (Peter), Zietek, B. (Barbara), Maroo, N. (Neera), Gay, L. (Laura), Underwood, T. (Tim), Boulter, L. (Lisa), McMurtry, H. (Hugh), Monk, A.B. (Alastair), Patel, P. (Poulam), Ragunath, K. (Krish), Al Dulaimi, D. (David), Murray, I. (Iain), Koss, C. (Clara), Veitch, A. (Andrew), Trudgill, N. (Nigel), Nwokolo, C. (Chuka), Rembacken, B., Atherfold, P. (Paul), Green, E.K. (Elaine K), Ang, Y. (Yeng), Kuipers, E.J. (Ernst), Chow, W. (Wu), Paterson, S. (Stuart), Kadri, S. (Sudarshan), Beales, I. (Ian), Grimley, C. (Charles), Mullins, P. (Paul), Beckett, C. (Conrad), Farrant, M. (Mark), Dixon, A. (Andrew), Kelly, S. (Sean), Johnson, M. (Matthew), Wajed, S. (Shahjehan), Dhar, A. (Archana), Sawyer, E.J. (Elinor), Roylance, R. (Rebecca), Onstad, L. (Lynn), Gammon, M.D. (Marilie), Corley, D.A. (Douglas), Shaheen, N. (Nazima), Bird, N.C. (Nigel), Hardie, B.G.S. (Bruce), Reid, B.J. (Brian), Ye, W. (Weimin), Liu, G. (Geoffrey), Romero, Y. (Yvonne), Bernstein, L. (Leslie), Wu, A.H. (Anna H.), Casson, A.G. (Alan), Fitzgerald, R.C. (Rebecca), Whiteman, D.C. (David C.), Risch, H. (Harvey), Levine, D.M. (David M.), Vaughan, T.L. (Thomas), Verhaar, A.P. (Auke), Van Den Brande, J. (Jan), Toxopeus, E.L.A. (Eelke), Spaander, M.C.W. (Manon), Wijnhoven, B.P.L. (Bas), Laan, L.J.W. (Luc) van der, Krishnadath, K.K. (Kausilia), Wijmenga, C. (Cisca), Trynka, G. (Gosia), McManus, R. (Ross), Reynolds, J.V. (John V.), O'Sullivan, J. (Jacintha), Macmathuna, P. (Padraic), McGarrigle, S.A. (Sarah A.), Kelleher, D. (Dermot), Vermeire, S. (Séverine), Cleynen, I. (Isabelle), Bisschops, R. (Raf), Tomlinson, I.P. (Ian), and Jankowski, J.A. (Janusz Antoni)
- Abstract
Background & Aims Barrett's esophagus (BE) increases the risk of esophageal adenocarcinoma (EAC). We found the risk to be BE has been associated with single nucleotide polymorphisms (SNPs) on chromosome 6p21 (within the HLA region) and on 16q23, where the closest protein-coding gene is FOXF1. Subsequently, the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON) identified risk loci for BE and esophageal adenocarcinoma near CRTC1 and BARX1, and within 100 kb of FOXP1. We aimed to identify further SNPs that increased BE risk and to validate previously reported associations. Methods We performed a genome-wide association study (GWAS) to identify variants associated with BE and further analyzed promising variants identified by BEACON by genotyping 10,158 patients with BE and 21,062 controls. Results We identified 2 SNPs not previously associated with BE: rs3072 (2p24.1; odds ratio [OR] = 1.14; 95% CI: 1.09-1.18; P = 1.8 × 10-11) and rs2701108 (12q24.21; OR = 0.90; 95% CI: 0.86-0.93; P = 7.5 × 10-9). The closest protein-coding genes were respectively GDF7 (rs3072), which encodes a ligand in the bone morphogenetic protein pathway, and TBX5 (rs2701108), which encodes a transcription factor that regulates esophageal and cardiac development. Our data also supported in BE cases 3 risk SNPs identified by BEACON (rs2687201, rs11789015, and rs10423674). Meta-analysis of all data identified another SNP associated with BE and esophageal adenocarcinoma: rs3784262, within ALDH1A2 (OR = 0.90; 95% CI: 0.87-0.93; P = 3.72 × 10-9). Conclusions We identified 2 loci associated with risk of BE and provided data to support a further locus. The genes we found to be associated with risk for BE encode transcription factors involved in thoracic, diaphragmatic, and esophageal development or proteins involved in the inflammatory response.
- Published
- 2015
- Full Text
- View/download PDF
13. The expression of the peripheral cannabinoid receptor CB2 has no effect on clinical outcome in diffuse large B-cell lymphomas
- Author
-
Rayman, N, Lam, King, van der Holt, Ronnie, Koss, C, van Leeuwen, Hans, Budel, LM (Leo), Mulder, AH (Andries), Sonneveld, P, Delwel, Ruud, Hematology, Pathology, and Internal Medicine
- Subjects
immune system diseases ,hemic and lymphatic diseases ,lipids (amino acids, peptides, and proteins) - Abstract
Background: The peripheral cannabinoid receptor (CB2) is mainly detected on B cells in the germinal centers (GCs) of the immune system, using an antibody directed against the extra cellular N-terminal domain of the receptor. We retrospectively investigated the CB2 receptor expression in diffuse large B-cell lymphomas (DLBCL) and its clinical relevance for treatment outcome. Patients and methods: We have constructed a tissue micro-array (TMA) using lymphoma tissue of a large cohort of patients with DLBCL (N = 104) who were treated with CHOP. Results: Forty-five out of 79 evaluable cases (57%) were CB2 positive. The expression of CB2 receptors was variably present in both the germinal center B cell (GCB) (n = 31) and the non-GCB/activated B-cell (ABC) (n = 43) DLBCL subtypes. CB2 positivity was not associated with a different outcome in this patient cohort (CR; P = 0.87, EFS; P = 0.32, DFS; P = 0.06 and OS; P = 0.18). Implementation of CB2 expression in the Hans algorithm using the markers CD10, BCL6, and MUM1 did not result in added prognostic value (all P-values > 0.1). Conclusions: We hypothesize that although CB2 is normally expressed in GCs, the expression in one of the malignant counterparts such as DLBCL is aberrant. This may be an explanation for the absence of prognostic relevance for the expression of this protein.
- Published
- 2011
14. An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia
- Author
-
Gruber, T, Larson Gedman, A, Zhang, J, Koss, C, Marada, S, Ta, H, Chen, S, Su, X, Ogden, S, Dang, J, Wu, G, Gupta, V, Andersson, A, Pounds, S, Sh, L, Easton, J, Barbato, M, Mulder, H, Manne, J, Wang, J, Rusch, M, Ranade, S, Ganti, R, Parker, M, Ma, J, Radtke, I, Ding, L, Cazzaniga, G, Biondi, A, Kornblau, S, Ravandi, F, Kantarjian, H, Nimer, S, Döhner, K, Döhner, H, Ley, T, Ballerini, P, Shurtleff, S, Tomizawa, D, Adachi, S, Hayashi, Y, Tawa, A, Shih, L, Liang, D, Rubnitz, J, Pui, C, Mardis, E, Wilson, R, Downing, J, Gruber, TA, Koss, CS, Ta, HQ, Chen, SC, Ogden, SK, Andersson, AK, Barbato, MI, Mulder, HL, Kornblau, SM, Nimer, SD, Ley, TJ, Shih, LY, Liang, DC, Rubnitz, JE, Pui, CH, Mardis, ER, Wilson, RK, Downing, JR, BIONDI, ANDREA, Gruber, T, Larson Gedman, A, Zhang, J, Koss, C, Marada, S, Ta, H, Chen, S, Su, X, Ogden, S, Dang, J, Wu, G, Gupta, V, Andersson, A, Pounds, S, Sh, L, Easton, J, Barbato, M, Mulder, H, Manne, J, Wang, J, Rusch, M, Ranade, S, Ganti, R, Parker, M, Ma, J, Radtke, I, Ding, L, Cazzaniga, G, Biondi, A, Kornblau, S, Ravandi, F, Kantarjian, H, Nimer, S, Döhner, K, Döhner, H, Ley, T, Ballerini, P, Shurtleff, S, Tomizawa, D, Adachi, S, Hayashi, Y, Tawa, A, Shih, L, Liang, D, Rubnitz, J, Pui, C, Mardis, E, Wilson, R, Downing, J, Gruber, TA, Koss, CS, Ta, HQ, Chen, SC, Ogden, SK, Andersson, AK, Barbato, MI, Mulder, HL, Kornblau, SM, Nimer, SD, Ley, TJ, Shih, LY, Liang, DC, Rubnitz, JE, Pui, CH, Mardis, ER, Wilson, RK, Downing, JR, and BIONDI, ANDREA
- Abstract
To define the mutation spectrum in non-Down syndrome acute megakaryoblastic leukemia (non-DS-AMKL), we performed transcriptome sequencing on diagnostic blasts from 14 pediatric patients and validated our findings in a recurrency/validation cohort consisting of 34 pediatric and 28 adult AMKL samples. Our analysis identified a cryptic chromosome 16 inversion (inv(16)(p13.3q24.3)) in 27% of pediatric cases, which encodes a CBFA2T3-GLIS2 fusion protein. Expression of CBFA2T3-GLIS2 in Drosophila and murine hematopoietic cells induced bone morphogenic protein (BMP) signaling and resulted in a marked increase in the self-renewal capacity of hematopoietic progenitors. These data suggest that expression of CBFA2T3-GLIS2 directly contributes to leukemogenesis
- Published
- 2012
15. „Tue Gutes und berichte darüber“ oder wie durch (freiwillige) Transparenz Vertrauen geschaffen werden kann
- Author
-
von Schnurbein, Georg, Zöbeli, D, Koss, Claus, von Schnurbein, G ( Georg ), Zöbeli, D ( D ), Koss, C ( Claus ), Eberle, Reto, von Schnurbein, Georg, Zöbeli, D, Koss, Claus, von Schnurbein, G ( Georg ), Zöbeli, D ( D ), Koss, C ( Claus ), and Eberle, Reto
- Published
- 2011
16. Transcriptome Sequence Analysis of Pediatric Acute Megakaryoblastic Leukemia Identifies An Inv(16)(p13.3;q24.3)-Encoded CBFA2T3-GLIS2 Fusion Protein As a Recurrent Lesion in 39% of Non-Infant Cases: A Report From the St. Jude Children's Research Hospital – Washington University Pediatric Cancer Genome Project
- Author
-
Gruber, T, Gedman, A, Ta, H, Zhang, J, Koss, C, Chen, S, Su, X, Gupta, V, Ogden, S, Andersson, A, Easton, J, Wang, J, Rusch, M, Ding, L, Cazzaniga, G, Biondi, A, Kornblau, S, Ravandi, F, Kantarjian, H, Nimer, S, Doehner, K, Doehner, H, Ley, T, Shurtleff, S, Rubnitz, J, Pui, C, Mardis, E, Wilson, R, Downing, J, Downing, J., BIONDI, ANDREA, Gruber, T, Gedman, A, Ta, H, Zhang, J, Koss, C, Chen, S, Su, X, Gupta, V, Ogden, S, Andersson, A, Easton, J, Wang, J, Rusch, M, Ding, L, Cazzaniga, G, Biondi, A, Kornblau, S, Ravandi, F, Kantarjian, H, Nimer, S, Doehner, K, Doehner, H, Ley, T, Shurtleff, S, Rubnitz, J, Pui, C, Mardis, E, Wilson, R, Downing, J, Downing, J., and BIONDI, ANDREA
- Published
- 2011
17. Polymer-polymer rectifying heterojunction based on poly(3,4-dicyanothiophene) and MEH-PPV
- Author
-
Greenwald, Y., primary, Xu, X., additional, Fourmigu�, M., additional, Srdanov, G., additional, Koss, C., additional, Wudl, F., additional, and Heeger, A. J., additional
- Published
- 1998
- Full Text
- View/download PDF
18. 3D Fibrotic Lung Extracellular Matrix Hydrogels Trigger Pro-Fibrotic Responses in Primary Lung Fibroblasts
- Author
-
Nizamoglu, M., Koster, T., Thomas, M., Wim Timens, Koss, C. K., El Kasmi, K. C., Melgert, B. N., Heijink, I. H., Burgess, J. K., Guided Treatment in Optimal Selected Cancer Patients (GUTS), Groningen Research Institute for Asthma and COPD (GRIAC), Molecular Pharmacology, and Restoring Organ Function by Means of Regenerative Medicine (REGENERATE)
- Abstract
Idiopathic Pulmonary Fibrosis (IPF) is characterized by the aberrant deposition and organization of extracellular matrix (ECM).Increased stiffness of fibrotic lung tissue is a major contributor to fibrosis by perpetuating fibrotic responses, through modulationof interactions between ECM-producing cells and fibrotic ECM. Human decellularized lung ECM-derived hydrogels can be usedas a model for mimicking the native three-dimensional (3D) microenvironment, including recapitulating the mechanicalenvironment in nonfibrotic (control) and fibrotic lung tissues. In this study, we aimed to characterize control and fibrotic human lungECM-derived 3D hydrogels seeded with primary lung fibroblasts to investigate the cellular remodeling responses dictated by theorigin of the microenvironment. IPF and control decellularized lung matrices were freeze-dried, ground to a fine powder, andmixed (pool of 7 donors per diagnosis) before pepsin digestion. Primary lung fibroblasts were isolated from lung tissue ofpatients with IPF (IPF) or macroscopically normal lung tissue derived from patients undergoing tumor resection (non-IPF). IPF ornon-IPF lung-derived fibroblasts (n=6 each) were resuspended in pH-neutralized ECM solutions and hydrogels were allowed toform before being cultured at 37°C, 5% CO2. Cell-seeded ECM-derived hydrogels were harvested on day 14 and their stiffnesswas measured using a Low-Load Compression Tester at 20% strain and compared with equivalent cell-free hydrogels. Cell-freeIPF hydrogels were stiffer than cell-free control hydrogels on day 14. Time in culture did not result in a difference in stiffness of cell-free hydrogels. The stiffness of control hydrogels seeded with either IPF or non-IPF fibroblasts did not change over a 14-dayculture period (Figure 1A, 1B). In contrast, the stiffness of IPF hydrogels was increased in the presence of non-IPF lungfibroblasts, compared to cell-free hydrogels over the 14 day period (Figure 1C) (p = 0.016). However, when IPF fibroblasts wereseeded in IPF hydrogels the stiffness of the hydrogel did not change compared to the cell-free counterpart (Figure 1D). Theseresults illustrate the importance of both the fibroblast-origin and the origin of the ECM in determining the response of thefibroblasts to the 3D ECM microenvironment. Specifically, the fibrotic microenvironment evoked a profibrotic response in non-IPFfibroblasts while IPF fibroblasts did not exhibit the same response in this microenvironment. Taken together, our data haveimplications for cellular therapies that rely on adding non-diseased cells to tissues to promote disease resolution, as well asrevealing the complexity of the positive feedback between fibrotic ECM and fibroblasts.
19. Erratum: C/EBPα deregulation results in differentiation arrest in acute myeloid leukemia (Journal of Clinical Investigation (2013) 123:1 (526) DOI: 10.1172/JCI68299)
- Author
-
Alberich-Jordà, M., Wouters, B., Balastik, M., Shapiro-Koss, C., Zhang, H., Di Ruscio, A., Radomska, H. S., Ebralidze, A. K., Amabile, G., Ye, M., Zhang, J., Lowers, I., Avellino, R., Melnick, A., Maria Eugenia Figueroa, Valk, P. J. M., Delwel, R., and Tenen, D. G.
20. ChemInform Abstract: ANHYDRIDE ACYLATION REACTIONS OF 2,4‐DINITROPHENYLHYDRAZINE
- Author
-
HEARN, M. J., primary, DEFURIO, L., additional, HURST, W., additional, KOSS, C., additional, LICTHMAN, M., additional, LUCAS, L., additional, MABROUK, P., additional, TENG, S., additional, and WAUD, C., additional
- Published
- 1983
- Full Text
- View/download PDF
21. C/EBPγ deregulation results in differentiation arrest in acute myeloid leukemia.
- Author
-
Alberich-Jordà M, Wouters B, Balastik M, Shapiro-Koss C, Zhang H, Diruscio A, Radomska HS, Ebralidze AK, Amabile G, Ye M, Zhang J, Lowers I, Avellino R, Melnick A, Figueroa ME, Valk PJ, Delwel R, Tenen DG, Alberich-Jordà, Meritxell, and Wouters, Bas
- Abstract
C/EBPs are a family of transcription factors that regulate growth control and differentiation of various tissues. We found that C/EBPγ is highly upregulated in a subset of acute myeloid leukemia (AML) samples characterized by C/EBPα hypermethylation/silencing. Similarly, C/EBPγ was upregulated in murine hematopoietic stem/progenitor cells lacking C/EBPα, as C/EBPα mediates C/EBPγ suppression. Studies in myeloid cells demonstrated that CEBPG overexpression blocked neutrophilic differentiation. Further, downregulation of Cebpg in murine Cebpa-deficient stem/progenitor cells or in human CEBPA-silenced AML samples restored granulocytic differentiation. In addition, treatment of these leukemias with demethylating agents restored the C/EBPα-C/EBPγ balance and upregulated the expression of myeloid differentiation markers. Our results indicate that C/EBPγ mediates the myeloid differentiation arrest induced by C/EBPα deficiency and that targeting the C/EBPα-C/EBPγ axis rescues neutrophilic differentiation in this unique subset of AMLs. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
22. An Inv(16)(p13.3q24.3)-Encoded CBFA2T3-GLIS2 Fusion Protein Defines an Aggressive Subtype of Pediatric Acute Megakaryoblastic Leukemia
- Author
-
Timothy J. Ley, James R. Downing, Xiaoping Su, Andrea Biondi, Jianmin Wang, Li Ding, Stanley Pounds, Tanja A. Gruber, Matthew Parker, Der Cherng Liang, Heather L. Mulder, Giovanni Cazzaniga, Jeffrey E. Rubnitz, Michael Rusch, Paola Ballerini, John Easton, Hartmut Döhner, Ching-Hon Pui, Ramapriya Ganti, Michael I. Barbato, Sheila A. Shurtleff, Farhad Ravandi, Jinghui Zhang, Richard K. Wilson, Yasuhide Hayashi, Lee Yung Shih, Huy Q. Ta, Ina Radtke, Steven M. Kornblau, Stacey K. Ogden, Amanda Larson Gedman, Anna Andersson, Daisuke Tomizawa, Jayanthi Manne, Vedant Gupta, Swati Ranade, Akio Tawa, Stephen D. Nimer, Shann Ching Chen, Gang Wu, Souichi Adachi, Konstanze Döhner, Lei Shi, Jing Ma, Suresh Marada, Jinjun Dang, Elaine R. Mardis, Hagop M. Kantarjian, Cary Koss, Gruber, T, Larson Gedman, A, Zhang, J, Koss, C, Marada, S, Ta, H, Chen, S, Su, X, Ogden, S, Dang, J, Wu, G, Gupta, V, Andersson, A, Pounds, S, Sh, L, Easton, J, Barbato, M, Mulder, H, Manne, J, Wang, J, Rusch, M, Ranade, S, Ganti, R, Parker, M, Ma, J, Radtke, I, Ding, L, Cazzaniga, G, Biondi, A, Kornblau, S, Ravandi, F, Kantarjian, H, Nimer, S, Döhner, K, Döhner, H, Ley, T, Ballerini, P, Shurtleff, S, Tomizawa, D, Adachi, S, Hayashi, Y, Tawa, A, Shih, L, Liang, D, Rubnitz, J, Pui, C, Mardis, E, Wilson, R, and Downing, J
- Subjects
0303 health sciences ,Mutation ,Cancer Research ,Cell Biology ,Biology ,medicine.disease_cause ,medicine.disease ,Bone morphogenetic protein ,Fusion protein ,Molecular biology ,Article ,3. Good health ,Gene expression profiling ,03 medical and health sciences ,Acute megakaryoblastic leukemia ,Haematopoiesis ,0302 clinical medicine ,Chromosome 16 ,AML ,Oncology ,030220 oncology & carcinogenesis ,medicine ,030304 developmental biology ,Chromosomal inversion - Abstract
To define the mutation spectrum in non-Down syndrome acute megkaryoblastic leukemia (non-DS-AMKL), we performed transcriptome sequencing on diagnostic blasts from 14 pediatric patients and validated our findings in a recurrency/validation cohort consisting of 34 pediatric and 28 adult AMKL leukemia samples. Our analysis identified a cryptic chromosome 16 inversion [inv(16)(p13.3q24.3)] in 27% of pediatric cases, which encodes a CBFA2T3-GLIS2 fusion protein. Expression of CBFA2T3-GLIS2 in Drosophila and murine hematopoietic cells induced bone morphogenic protein (BMP) signaling, and resulted in a marked increase in the self-renewal capacity of hematopoietic progenitors. These data suggest that expression of CBFA2T3-GLIS2 directly contributes to leukemogenesis.
- Published
- 2012
- Full Text
- View/download PDF
23. Transcriptome Sequence Analysis of Pediatric Acute Megakaryoblastic Leukemia Identifies An Inv(16)(p13.3;q24.3)-Encoded CBFA2T3-GLIS2 Fusion Protein As a Recurrent Lesion in 39% of Non-Infant Cases: A Report From the St. Jude Children's Research Hospital – Washington University Pediatric Cancer Genome Project
- Author
-
Richard K. Wilson, John Easton, Vedant Gupta, Michael Rusch, Konstanze Doehner, Huy Q. Ta, Farhad Ravandi, Tanja A. Gruber, Jinghui Zhang, Jeffrey E. Rubnitz, Sheila A. Shurtleff, Hartmut Doehner, Shann-Ching Chen, Timothy J. Ley, Stephen D. Nimer, Anna Andersson, Xiaoping Su, Elaine R. Mardis, Li Ding, Stacey K. Ogden, Amanda Larson Gedman, Giovanni Cazzaniga, Hagop M. Kantarjian, Cary Koss, Andrea Biondi, Steven M. Kornblau, Ching-Hon Pui, James R. Downing, Jianmin Wang, Gruber, T, Gedman, A, Ta, H, Zhang, J, Koss, C, Chen, S, Su, X, Gupta, V, Ogden, S, Andersson, A, Easton, J, Wang, J, Rusch, M, Ding, L, Cazzaniga, G, Biondi, A, Kornblau, S, Ravandi, F, Kantarjian, H, Nimer, S, Doehner, K, Doehner, H, Ley, T, Shurtleff, S, Rubnitz, J, Pui, C, Mardis, E, Wilson, R, and Downing, J
- Subjects
Myeloid ,Immunology ,GATA2 ,Transcriptome Sequence Analysis ,Cell Biology ,Hematology ,Chimeric gene ,Biology ,medicine.disease ,Biochemistry ,Fusion protein ,Pediatric cancer ,Leukemia ,Acute megakaryoblastic leukemia ,medicine.anatomical_structure ,Pediatric Acute Megakaryoblastic Leukemia ,FLI1 ,medicine ,Cancer research - Abstract
Abstract 757 Acute Megakaryoblastic Leukemia (AMKL) accounts for ∼10% of childhood acute myeloid leukemia (AML). Although AMKL patients with down syndrome (DS-AMKL) have an excellent 5 year event-free survival (EFS), non-DS-AMKL patients have an extremely poor outcome with a 3 year EFS of less than 40%. With the exception of the t(1;22) translocation seen in infant non-DS-AMKL, little is known about the molecular genetic lesions that underlie this leukemia subtype. To define the landscape of mutations that occur in non-DS-AMKL, we performed transcriptome sequencing on diagnostic blasts from 14 cases (discovery cohort) using the illumina platform. Our results identified chromosomal rearrangements resulting in the expression of novel fusion transcripts in 12/14 cases. Remarkably, in 7/14 cases we detected an inversion on chromosome 16 [inv(16)(p13.3;q24.3)] that resulted in the juxtaposition of the CBFA2T3, a member of the ETO family of transcription factors, next to GLIS2 resulting in a CBFA2T3-GLIS2 chimeric gene encoding an in frame fusion protein. 6 cases in the discovery cohort fused exon 10 of CBFA2T3 to exon 3 of GLIS2, while 1 case carried a larger product that fused exon 11 of CBFA2T3 to exon 1 of GLIS2. Both products retain the 3 CBFA2T3 N-terminal nervy homology regions that mediate protein interactions, and the 5 GLIS2 C-terminal zinc finger domains that bind the Glis DNA consensus sequence, along with one of its N-terminal transcriptional regulatory domains. GLIS2 is a member of the GLI super family of transcription factors and has been demonstrated to play a role in regulating expression of GLI target genes as well as inhibiting WNT signaling through the binding of beta catenin. Although GLIS2 is not normally expressed in hematopoietic cells, the translocation results in high level expression of the CBFA2T3-GLIS2 fusion protein. In addition to CBFA2T3-GLIS2, chimeric transcripts were detected in 6/7 cases that lacked evidence of the inv(16)(p13.3;q24.3). Specifically, we detected GATA2-HOXA9, MN1-FLI1, NIPBL-HOXB9, NUP98-KDM5A, GRB10-SDK1 and C8orf76-HOXA11AS, each in an individual case. Importantly, several of the genes involved in these translocations either play a direct role in normal megakaryocytic differentiation (GATA2 and FLI1), or have been previously shown to be involved in leukemogenesis (HOXA9, MN1, HOXB9). Evaluation of a recurrency cohort of 42 samples including 14 additional pediatric cases and 28 adult cases by RT-PCR revealed 4 additional pediatric samples carrying CBFA2T3-GLIS2 for an overall frequency of 39% in pediatric AMKL. In addition to these somatic structural variations, we also identified mutations in genes previously shown to play a role in megakaryoblastic leukemia including activating mutations in JAK2 and MPL (36%). To gain insight into the mechanism whereby CBFA2T3-GLIS2 promotes leukemogenesis, we introduced the fusion into murine hematopoietic cells and assessed its effect on in vitro colony replating as a surrogate measure of self-renewal. Hematopoietic cells transduced with a mCherry expressing retroviral vector failed to form colonies after the second replating. By contrast, expression of either wild-type GLIS2 or the CBFA2T3-GLIS2 fusion resulted in a marked increase in the self-renewal capacity, with colony formation persisting through eight replatings. Immunophenotypic analysis of the CBFA2T3-GLIS2 expressing colonies revealed evidence of megakaryocytic differentiation. Importantly, the CBFA2T3-GLIS2 cells remained growth factor dependent suggesting that cooperating mutations in growth factor signaling pathways are required for full leukemic transformation. Taken together these data identify a novel cryptic inv(16)-encoded CBFA2T3-GLIS2 fusion protein as a recurrent driver mutation in approximately 40% of non-infant pediatric non-DS-AMKLs. Moreover, the majority of pediatric cases that lacked this lesion were shown by transcriptome sequence analysis to contain other chromosomal rearrangements that encoded fusion proteins that directly alter megakaryocytic differentiation and/or myeloid cell growth. The alteration of a key transcriptional regulator within the hedgehog signaling pathways in a substantial percentage of pediatric AMKL raises the possibility that inhibition of this pathway may have a therapeutic benefit in this aggressive form of AML. *TAG and ALG contributed equally to this work. Disclosures: Biondi: BMS, Novartis, Micromed: Consultancy, Membership on an entity's Board of Directors or advisory committees. Ravandi:Bristol Myers Squibb: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Novartis: Honoraria. Kantarjian:Novartis: Consultancy, Research Funding; Pfizer: Research Funding; BMS: Research Funding. Doehner:Hoffmann La Roche: Honoraria.
- Published
- 2011
24. Influence of reinforcement and its omission on trial-by-trial changes of response bias in perceptual decision making.
- Author
-
Stüttgen MC, Dietl A, Stoilova Eckert VV, de la Cuesta-Ferrer L, Blanke JH, Koß C, and Jäkel F
- Subjects
- Animals, Rats, Male, Models, Psychological, Signal Detection, Psychological, Conditioning, Operant, Choice Behavior, Acoustic Stimulation, Discrimination, Psychological, Reinforcement, Psychology, Decision Making, Discrimination Learning
- Abstract
Discrimination performance in perceptual choice tasks is known to reflect both sensory discriminability and nonsensory response bias. In the framework of signal detection theory, these aspects of discrimination performance are quantified through separate measures, sensitivity (d') for sensory discriminability and decision criterion (c) for response bias. However, it is unknown how response bias (i.e., criterion) changes at the single-trial level as a consequence of reinforcement history. We subjected rats to a two-stimulus two-response conditional discrimination task with auditory stimuli and induced response bias through unequal reinforcement probabilities for the two responses. We compared three signal-detection-theory-based criterion learning models with respect to their ability to fit experimentally observed fluctuations of response bias on a trial-by-trial level. These models shift the criterion by a fixed step (1) after each reinforced response or (2) after each nonreinforced response or (3) after both. We find that all three models fail to capture essential aspects of the data. Prompted by the observation that steady-state criterion values conformed well to a behavioral model of signal detection based on the generalized matching law, we constructed a trial-based version of this model and find that it provides a superior account of response bias fluctuations under changing reinforcement contingencies., (© 2024 The Authors. Journal of the Experimental Analysis of Behavior published by Wiley Periodicals LLC on behalf of Society for the Experimental Analysis of Behavior.)
- Published
- 2024
- Full Text
- View/download PDF
25. Safety and Effect of Bariatric Metabolic Surgeries for Psychiatric Patients with Obesity: A Retrospective Matched Case-control Trial.
- Author
-
Hany M, Aboudeeb MF, Shapiro-Koss C, Agayby ASS, and Torensma B
- Subjects
- Humans, Retrospective Studies, Case-Control Studies, Obesity complications, Obesity surgery, Treatment Outcome, Weight Loss, Obesity, Morbid surgery, Bariatric Surgery
- Abstract
Introduction: Patients living with psychiatric illnesses (PIs) have a high prevalence of obesity. In a 2006 survey, 91.2% of professionals in the bariatric field identified "psychiatric issues" as clear contraindications to weight-loss surgery., Methods: This retrospective matched case-control study investigated the impact, safety, and possible relapse after bariatric metabolic surgery (BMS) in patients with PIs. Also, we tested the incidence of patients who developed PI after BMS and compared the post-procedural weight loss with that in a matched control group without PIs. The cases were matched in a ratio of 1:4 to the control patients standardized for age, sex, preoperative BMI, and type of BMS., Results: Of 5987 patients, 2.82% had a preoperative PI; postoperative de novo PI was present in 0.45%. Postoperative BMI was significantly different between the groups when compared to preoperative BMI (p < 0.001). Percentage of total weight loss (%TWL) after six months was not significantly different between the case (24.6% ± 8.9) and control groups (24.0% ± 8.4, p = 1.000). Early and late complications were not significantly different between the groups. The psychiatric drug use and dosage changes did not differ significantly pre- and postoperatively. Of the psychiatric patients, 5.1% were postoperatively admitted to a psychiatric hospital (p = 0.06) unrelated to BMS, and 3.4% had a prolonged absence from work after surgery., Conclusion: BMS is an effective weight loss treatment and a safe procedure for patients with psychiatric disorders. We found no change in the patients' psychiatric status outside the usual disease course. Postoperative de novo PI was rare in the present study. Furthermore, patients with severe psychiatric illness were excluded from undergoing surgery and, therefore, from the study. Careful follow-up is necessary to guide and protect patients with PI., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
26. Author Correction: Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia.
- Author
-
Kamens JL, Nance S, Koss C, Xu B, Cotton A, Lam JW, Garfinkle EAR, Nallagatla P, Smith AMR, Mitchell S, Ma J, Currier D, Wright WC, Kavdia K, Pagala VR, Kim W, Wallace LM, Cho JH, Fan Y, Seth A, Twarog N, Choi JK, Obeng EA, Hatley ME, Metzger ML, Inaba H, Jeha S, Rubnitz JE, Peng J, Chen T, Shelat AA, Guy RK, and Gruber TA
- Published
- 2023
- Full Text
- View/download PDF
27. Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia.
- Author
-
Kamens JL, Nance S, Koss C, Xu B, Cotton A, Lam JW, Garfinkle EAR, Nallagatla P, Smith AMR, Mitchell S, Ma J, Currier D, Wright WC, Kavdia K, Pagala VR, Kim W, Wallace LM, Cho JH, Fan Y, Seth A, Twarog N, Choi JK, Obeng EA, Hatley ME, Metzger ML, Inaba H, Jeha S, Rubnitz JE, Peng J, Chen T, Shelat AA, Guy RK, and Gruber TA
- Subjects
- Infant, Adult, Humans, Child, Lysine genetics, Myeloid-Lymphoid Leukemia Protein genetics, Transcriptome, Proteasome Endopeptidase Complex genetics, Precursor Cell Lymphoblastic Leukemia-Lymphoma drug therapy, Precursor Cell Lymphoblastic Leukemia-Lymphoma genetics
- Abstract
Rearrangments in Histone-lysine-N-methyltransferase 2A (KMT2Ar) are associated with pediatric, adult and therapy-induced acute leukemias. Infants with KMT2Ar acute lymphoblastic leukemia (ALL) have a poor prognosis with an event-free-survival of 38%. Herein we evaluate 1116 FDA approved compounds in primary KMT2Ar infant ALL specimens and identify a sensitivity to proteasome inhibition. Upon exposure to this class of agents, cells demonstrate a depletion of histone H2B monoubiquitination (H2Bub1) and histone H3 lysine 79 dimethylation (H3K79me2) at KMT2A target genes in addition to a downregulation of the KMT2A gene expression signature, providing evidence that it targets the KMT2A transcriptional complex and alters the epigenome. A cohort of relapsed/refractory KMT2Ar patients treated with this approach on a compassionate basis had an overall response rate of 90%. In conclusion, we report on a high throughput drug screen in primary pediatric leukemia specimens whose results translate into clinically meaningful responses. This innovative treatment approach is now being evaluated in a multi-institutional upfront trial for infants with newly diagnosed ALL., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
28. The Association Between Social Network Characteristics and Tuberculosis Infection Among Adults in 9 Rural Ugandan Communities.
- Author
-
Marquez C, Chen Y, Atukunda M, Chamie G, Balzer LB, Kironde J, Ssemmondo E, Mwangwa F, Kabami J, Owaraganise A, Kakande E, Abbott R, Ssekyanzi B, Koss C, Kamya MR, Charlebois ED, Havlir DV, and Petersen ML
- Subjects
- Adult, Male, Humans, Female, Uganda epidemiology, Rural Population, Tuberculin Test, Mycobacterium tuberculosis, Tuberculosis epidemiology, Latent Tuberculosis, HIV Infections complications, HIV Infections epidemiology
- Abstract
Background: Social network analysis can elucidate tuberculosis transmission dynamics outside the home and may inform novel network-based case-finding strategies., Methods: We assessed the association between social network characteristics and prevalent tuberculosis infection among residents (aged ≥15 years) of 9 rural communities in Eastern Uganda. Social contacts named during a census were used to create community-specific nonhousehold social networks. We evaluated whether social network structure and characteristics of first-degree contacts (sex, human immunodeficiency virus [HIV] status, tuberculosis infection) were associated with revalent tuberculosis infection (positive tuberculin skin test [TST] result) after adjusting for individual-level risk factors (age, sex, HIV status, tuberculosis contact, wealth, occupation, and Bacillus Calmette-Guérin [BCG] vaccination) with targeted maximum likelihood estimation., Results: Among 3 335 residents sampled for TST, 32% had a positive TST results and 4% reported a tuberculosis contact. The social network contained 15 328 first-degree contacts. Persons with the most network centrality (top 10%) (adjusted risk ratio, 1.3 [95% confidence interval, 1.1-1.1]) and the most (top 10%) male contacts (1.5 [1.3-1.9]) had a higher risk of prevalent tuberculosis, than those in the remaining 90%. People with ≥1 contact with HIV (adjusted risk ratio, 1.3 [95% confidence interval, 1.1-1.6]) and ≥2 contacts with tuberculosis infection were more likely to have tuberculosis themselves (2.6 [ 95% confidence interval: 2.2-2.9])., Conclusions: Social networks with higher centrality, more men, contacts with HIV, and tuberculosis infection were positively associated with tuberculosis infection. Tuberculosis transmission within measurable social networks may explain prevalent tuberculosis not associated with a household contact. Further study on network-informed tuberculosis case finding interventions is warranted., Competing Interests: Potential conflicts of interest. G. C. reports participation on a data safety monitoring board or advisory board as a member of a data monitoring committee for an National Institutes of Health (NIH)–funded clinical trial (TB Screening Improves Preventive Therapy Uptake [TB SCRIPT] trial). E. D. C. reports support from the NIH (grant 1R01AI151209-01 [paid to institution]) and consulting fees from the Infectious Diseases Research Collaboration, Kampala, Uganda (paid to the author for Integrated HIV & Hypertension Study consulting). D. V. H. reports nonfinancial support from Gilead (drug donation for an NIH study) and Abbott (diagnostic test donation). All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed., (© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
29. Benefits and detriments of interdisciplinarity on early career scientists' performance. An author-level approach for U.S. physicists and psychologists.
- Author
-
Unger S, Erhard L, Wieczorek O, Koß C, Riebling J, and Heiberger RH
- Subjects
- Humans, Interdisciplinary Research, Interdisciplinary Studies, Research Report, Physics, Research Personnel
- Abstract
Is the pursuit of interdisciplinary or innovative research beneficial or detrimental for the impact of early career researchers? We focus on young scholars as they represent an understudied population who have yet to secure a place within academia. Which effects promise higher scientific recognition (i.e., citations) is therefore crucial for the high-stakes decisions young researchers face. To capture these effects, we introduce measurements for interdisciplinarity and novelty that can be applied to a researcher's career. In contrast to previous studies investigating research impact on the paper level, hence, our paper focuses on a career perspective (i.e., the level of authors). To consider different disciplinary cultures, we utilize a comprehensive dataset on U.S. physicists (n = 4003) and psychologists (n = 4097), who graduated between 2008 and 2012, and traced their publication records. Our results indicate that conducting interdisciplinary research as an early career researcher in physics is beneficial, while it is negatively associated with research impact in psychology. In both fields, physics and psychology, early career researchers focusing on novel combinations of existing knowledge are associated with higher future impact. Taking some risks by deviating to a certain degree from mainstream paradigms seems therefore like a rewarding strategy for young scholars., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2022
- Full Text
- View/download PDF
30. No evidence of impaired visual and tactile metacognition in adults with tourette disorder.
- Author
-
Arbuzova P, Guo S, Koß C, Kurvits L, Faivre N, Kühn AA, Filevich E, and Ganos C
- Subjects
- Adult, Case-Control Studies, Humans, Severity of Illness Index, Metacognition, Tic Disorders, Tics, Tourette Syndrome complications
- Abstract
Introduction: Premonitory urges in Tourette disorder are often linked to altered somatosensory processing, which might include deficits in metacognition. We explored tactile and visual metacognitive ability in people with Tourette disorder and healthy control participants., Methods: Patients with Tourrete disorder and healthy control participants completed a tactile and a visual metacognitive task. On each trial, participants did a forced choice discrimination and then rated their confidence in their decision. To quantify metacognitive ability, we used m-ratio - a bias-free measure that allows for comparisons across modalities. Correlations between severity of tics and premonitory urges with tactile metacognitive sensitivity were also performed., Results: Metacognitive ability in both tactile and visual domains was comparable between adults with Tourette disorder and healthy controls. We also found no evidence for correlations between tactile metacognitive ability and severity of premonitory urges or tic severity., Conclusions: Tactile and visual metacognition is not impaired in adults with Tourette disorder. These results question the role of altered tactile metacognition in pathophysiology of tic disorders., (Copyright © 2022 Elsevier Ltd. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
31. Measuring metacognition of direct and indirect parameters of voluntary movement.
- Author
-
Arbuzova P, Peters C, Röd L, Koß C, Maurer H, Maurer LK, Müller H, Verrel J, and Filevich E
- Subjects
- Humans, Judgment, Movement, Metacognition
- Abstract
We can make exquisitely precise movements without the apparent need for conscious monitoring. But can we monitor the low-level movement parameters when prompted? And what are the mechanisms that allow us to monitor our movements? To answer these questions, we designed a semivirtual ball throwing task. On each trial, participants first threw a virtual ball by moving their arm (with or without visual feedback, or replayed from a previous trial) and then made a two-alternative forced choice on the resulting ball trajectory. They then rated their confidence in their decision. We measured metacognitive efficiency using meta-d'/d' and compared it between different informational domains of the first-order task (motor, visuomotor or visual information alone), as well as between two different versions of the task based on different parameters of the movement: proximal (position of the arm) or distal (resulting trajectory of the ball thrown). We found that participants were able to monitor their performance based on distal motor information as well as when proximal information was available. Their metacognitive efficiency was also equally high in conditions with different sources of information available. The analysis of correlations across participants revealed an unexpected result: While metacognitive efficiency correlated between informational domains (which would indicate domain-generality of metacognition), it did not correlate across the different parameters of movement. We discuss possible sources of this discrepancy and argue that specific first-order task demands may play a crucial role in our metacognitive ability and should be considered when making inferences about domain-generality based on correlations. (PsycInfo Database Record (c) 2022 APA, all rights reserved).
- Published
- 2021
- Full Text
- View/download PDF
32. Does a Positive Response to Lithium Augmentation in Resistant Major Depression Indicate a Bipolar Disorder?: A Long-Term Follow-up Study.
- Author
-
Birkenhager TK, Shapiro-Koss C, and Kamperman AM
- Subjects
- Adult, Bipolar Disorder diagnosis, Depressive Disorder, Major physiopathology, Depressive Disorder, Treatment-Resistant physiopathology, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, Male, Middle Aged, Retrospective Studies, Treatment Outcome, Antidepressive Agents administration & dosage, Depressive Disorder, Major drug therapy, Depressive Disorder, Treatment-Resistant drug therapy, Lithium Compounds administration & dosage
- Published
- 2021
- Full Text
- View/download PDF
33. Response-Related Signals Increase Confidence But Not Metacognitive Performance.
- Author
-
Filevich E, Koß C, and Faivre N
- Subjects
- Brain, Decision Making, Humans, Judgment, Reaction Time, Metacognition
- Abstract
Confidence judgments are a central tool in metacognition research. In a typical task, participants first perform perceptual (first-order) decisions and then rate their confidence in these decisions. The relationship between confidence and first-order accuracy is taken as a measure of metacognitive performance. Confidence is often assumed to stem from decision-monitoring processes alone, but processes that co-occur with the first-order decision may also play a role in confidence formation. In fact, some recent studies have revealed that directly manipulating motor regions in the brain, or the time of first-order decisions relative to second-order decisions, affects confidence judgments. This finding suggests that confidence could be informed by a readout of reaction times in addition to decision-monitoring processes. To test this possibility, we assessed the contribution of response-related signals to confidence and, in particular, to metacognitive performance (i.e., a measure of the adequacy of these confidence judgments). In human volunteers, we measured the effect of making an overt (vs covert) decision, as well as the effect of pairing an action to the stimulus about which the first-order decision is made. Against our expectations, we found no differences in overall confidence or metacognitive performance when first-order responses were covert as opposed to overt. Further, actions paired to visual stimuli presented led to higher confidence ratings, but did not affect metacognitive performance. These results suggest that confidence ratings do not always incorporate motor information., (Copyright © 2020 Filevich et al.)
- Published
- 2020
- Full Text
- View/download PDF
34. The Confidence Database.
- Author
-
Rahnev D, Desender K, Lee ALF, Adler WT, Aguilar-Lleyda D, Akdoğan B, Arbuzova P, Atlas LY, Balcı F, Bang JW, Bègue I, Birney DP, Brady TF, Calder-Travis J, Chetverikov A, Clark TK, Davranche K, Denison RN, Dildine TC, Double KS, Duyan YA, Faivre N, Fallow K, Filevich E, Gajdos T, Gallagher RM, de Gardelle V, Gherman S, Haddara N, Hainguerlot M, Hsu TY, Hu X, Iturrate I, Jaquiery M, Kantner J, Koculak M, Konishi M, Koß C, Kvam PD, Kwok SC, Lebreton M, Lempert KM, Ming Lo C, Luo L, Maniscalco B, Martin A, Massoni S, Matthews J, Mazancieux A, Merfeld DM, O'Hora D, Palser ER, Paulewicz B, Pereira M, Peters C, Philiastides MG, Pfuhl G, Prieto F, Rausch M, Recht S, Reyes G, Rouault M, Sackur J, Sadeghi S, Samaha J, Seow TXF, Shekhar M, Sherman MT, Siedlecka M, Skóra Z, Song C, Soto D, Sun S, van Boxtel JJA, Wang S, Weidemann CT, Weindel G, Wierzchoń M, Xu X, Ye Q, Yeon J, Zou F, and Zylberberg A
- Subjects
- Adult, Choice Behavior physiology, Datasets as Topic statistics & numerical data, Humans, Reaction Time physiology, Databases, Factual statistics & numerical data, Mental Processes physiology, Metacognition physiology, Psychometrics instrumentation, Psychometrics statistics & numerical data, Task Performance and Analysis
- Abstract
Understanding how people rate their confidence is critical for the characterization of a wide range of perceptual, memory, motor and cognitive processes. To enable the continued exploration of these processes, we created a large database of confidence studies spanning a broad set of paradigms, participant populations and fields of study. The data from each study are structured in a common, easy-to-use format that can be easily imported and analysed using multiple software packages. Each dataset is accompanied by an explanation regarding the nature of the collected data. At the time of publication, the Confidence Database (which is available at https://osf.io/s46pr/) contained 145 datasets with data from more than 8,700 participants and almost 4 million trials. The database will remain open for new submissions indefinitely and is expected to continue to grow. Here we show the usefulness of this large collection of datasets in four different analyses that provide precise estimations of several foundational confidence-related effects.
- Published
- 2020
- Full Text
- View/download PDF
35. HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa.
- Author
-
Havlir DV, Balzer LB, Charlebois ED, Clark TD, Kwarisiima D, Ayieko J, Kabami J, Sang N, Liegler T, Chamie G, Camlin CS, Jain V, Kadede K, Atukunda M, Ruel T, Shade SB, Ssemmondo E, Byonanebye DM, Mwangwa F, Owaraganise A, Olilo W, Black D, Snyman K, Burger R, Getahun M, Achando J, Awuonda B, Nakato H, Kironde J, Okiror S, Thirumurthy H, Koss C, Brown L, Marquez C, Schwab J, Lavoy G, Plenty A, Mugoma Wafula E, Omanya P, Chen YH, Rooney JF, Bacon M, van der Laan M, Cohen CR, Bukusi E, Kamya MR, and Petersen M
- Subjects
- AIDS-Related Opportunistic Infections diagnosis, AIDS-Related Opportunistic Infections epidemiology, Adolescent, Adult, Female, HIV Infections diagnosis, HIV Infections epidemiology, HIV Infections mortality, Humans, Incidence, Kenya epidemiology, Male, Middle Aged, Patient-Centered Care, Prevalence, Socioeconomic Factors, Tuberculosis diagnosis, Tuberculosis epidemiology, Uganda epidemiology, Viral Load, Young Adult, Anti-Retroviral Agents therapeutic use, Community Health Services, HIV Infections drug therapy, Mass Drug Administration, Mass Screening
- Abstract
Background: Universal antiretroviral therapy (ART) with annual population testing and a multidisease, patient-centered strategy could reduce new human immunodeficiency virus (HIV) infections and improve community health., Methods: We randomly assigned 32 rural communities in Uganda and Kenya to baseline HIV and multidisease testing and national guideline-restricted ART (control group) or to baseline testing plus annual testing, eligibility for universal ART, and patient-centered care (intervention group). The primary end point was the cumulative incidence of HIV infection at 3 years. Secondary end points included viral suppression, death, tuberculosis, hypertension control, and the change in the annual incidence of HIV infection (which was evaluated in the intervention group only)., Results: A total of 150,395 persons were included in the analyses. Population-level viral suppression among 15,399 HIV-infected persons was 42% at baseline and was higher in the intervention group than in the control group at 3 years (79% vs. 68%; relative prevalence, 1.15; 95% confidence interval [CI], 1.11 to 1.20). The annual incidence of HIV infection in the intervention group decreased by 32% over 3 years (from 0.43 to 0.31 cases per 100 person-years; relative rate, 0.68; 95% CI, 0.56 to 0.84). However, the 3-year cumulative incidence (704 incident HIV infections) did not differ significantly between the intervention group and the control group (0.77% and 0.81%, respectively; relative risk, 0.95; 95% CI, 0.77 to 1.17). Among HIV-infected persons, the risk of death by year 3 was 3% in the intervention group and 4% in the control group (0.99 vs. 1.29 deaths per 100 person-years; relative risk, 0.77; 95% CI, 0.64 to 0.93). The risk of HIV-associated tuberculosis or death by year 3 among HIV-infected persons was 4% in the intervention group and 5% in the control group (1.19 vs. 1.50 events per 100 person-years; relative risk, 0.79; 95% CI, 0.67 to 0.94). At 3 years, 47% of adults with hypertension in the intervention group and 37% in the control group had hypertension control (relative prevalence, 1.26; 95% CI, 1.15 to 1.39)., Conclusions: Universal HIV treatment did not result in a significantly lower incidence of HIV infection than standard care, probably owing to the availability of comprehensive baseline HIV testing and the rapid expansion of ART eligibility in the control group. (Funded by the National Institutes of Health and others; SEARCH ClinicalTrials.gov number, NCT01864603.)., (Copyright © 2019 Massachusetts Medical Society.)
- Published
- 2019
- Full Text
- View/download PDF
36. The dog that didn't bark: The challenge of cross-cultural qualitative research on aging.
- Author
-
Lessenich S, Ekerdt DJ, Münch A, Koss C, Li AY, and Fung HH
- Subjects
- Aged, Germany, Hong Kong, Humans, Qualitative Research, United States, Aging psychology, Cross-Cultural Comparison, Cultural Characteristics, Health Services for the Aged
- Abstract
The paper addresses the problem of cultural proximity in qualitative cross-cultural research on aging, presenting insights into a methodology of systematic 'estrangement'. Based on interdisciplinary research on the social time orientations of elderly people in Germany, Hong Kong, and the US, we discuss the question of how shared identities and taken-for-granted assumptions may bias the findings in comparative aging studies. With Alfred Schütz's phenomenological concept of 'lifeworld' as a methodological device, we focus on the issue of the diverging 'systems of relevance' that each of the national project teams obviously referred to when gathering and interpreting the data. The paper suggests that, by way of organizing an interactive research setting that is open for the reciprocity of perspectives, one of the major problems for cross-cultural research on aging may be overcome or at least mitigated., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
37. Encounters With Health-Care Providers and Advance Directive Completion by Older Adults.
- Author
-
Koss C
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Logistic Models, Male, United States, Advance Care Planning statistics & numerical data, Advance Directives psychology, Advance Directives statistics & numerical data, Health Personnel psychology, Hospice Care psychology
- Abstract
Background: The Patient Self-Determination Act (PSDA) requires hospitals, home health agencies, nursing homes, and hospice providers to offer new patients information about advance directives. There is little evidence regarding whether encounters with these health-care providers prompt advance directive completion by patients., Objective: To examine whether encounters with various types of health-care providers were associated with higher odds of completing advance directives by older patients., Method: Logistic regression using longitudinal data from the 2012 and 2014 waves of the Health and Retirement Study. Participants were 3752 US adults aged 65 and older who reported not possessing advance directives in 2012. Advance directive was defined as a living will and/or durable power of attorney for health care. Four binary variables measured whether participants had spent at least 1 night in a hospital, underwent outpatient surgery, received home health or hospice care, or spent at least one night in a nursing home between 2012 and 2014., Results: Older adults who received hospital, nursing home, or home health/hospice care were more likely to complete advance directives. Outpatient surgery was not associated with advance directive completion., Conclusions: Older adults with no advance directive in 2012 who encountered health-care providers covered by the PSDA were more likely to have advance directives by 2014. The exception was outpatient surgery which is frequently provided in freestanding surgery centers not subject to PSDA mandates. It may be time to consider amending the PSDA to cover freestanding surgery centers.
- Published
- 2018
- Full Text
- View/download PDF
38. Residential Reasoning and the Tug of the Fourth Age.
- Author
-
Koss C and Ekerdt DJ
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Independent Living, Male, Qualitative Research, Decision Making, Housing, Residence Characteristics
- Abstract
Purpose of the Study: Where to grow older occupies the minds of many aging adults. This study examines how anticipation of the fourth age influences third-age residential reasoning. It also investigates the role of social relationships in choosing housing for later life., Design and Methods: Analyses were based on semi-structured interviews with 30 community-dwelling retirees aged 67-97 who were asked about preparations for the future, including housing., Results: Replies about future housing fell into two categories: preemptive and contingent. In preemptive reasoning, participants anticipated that their current homes would be suitable over the long term and explained why, while those engaged in contingent reasoning could imagine a possible future move to more supportive housing and even had destination places in mind. Both types of responses reflect residential reasoning that is ongoing and driven in large part by anticipation of fourth-age vulnerabilities. Peers influenced participants' thinking about whether, when, and where to move. Relationships with spouses and offspring were also factors commonly mentioned in residential reasoning, both in terms of sources of support and perceived obligations., Implications: The fourth age is generally conceived as an experience of loss, but it also functions as a social imaginary. Our study suggests that the fourth age, both as a potential personal destiny and a social construct, influences housing decisions among those firmly in the third age. More attention in housing research to prudential anticipation of the fourth age as well as the relational aspects of residential reasoning would enhance understanding of late-life housing choices., (© The Author 2016. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2017
- Full Text
- View/download PDF
39. Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria Chemoprevention.
- Author
-
Kajubi R, Huang L, Jagannathan P, Chamankhah N, Were M, Ruel T, Koss CA, Kakuru A, Mwebaza N, Kamya M, Havlir D, Dorsey G, Rosenthal PJ, and Aweeka FT
- Subjects
- Adolescent, Adult, Alkynes, Antimalarials pharmacokinetics, Area Under Curve, Artemisinins pharmacokinetics, Chemoprevention methods, Cyclopropanes, Dose-Response Relationship, Drug, Drug Combinations, Drug Interactions, Female, HIV Infections drug therapy, Humans, Pregnancy, Pregnancy Complications, Infectious drug therapy, Pregnancy Complications, Parasitic prevention & control, Quinolines pharmacokinetics, Reverse Transcriptase Inhibitors administration & dosage, Uganda, Young Adult, Antimalarials administration & dosage, Artemisinins administration & dosage, Benzoxazines administration & dosage, Malaria prevention & control, Quinolines administration & dosage
- Abstract
Dihydroartemisinin (DHA)-piperaquine is promising for malaria chemoprevention in pregnancy. We assessed the impacts of pregnancy and efavirenz-based antiretroviral therapy on exposure to DHA and piperaquine in pregnant Ugandan women. Intensive sampling was performed at 28 weeks gestation in 31 HIV-uninfected pregnant women, in 27 HIV-infected pregnant women receiving efavirenz, and in 30 HIV-uninfected nonpregnant women. DHA peak concentration and area under the concentration time curve (AUC
0-8hr ) were 50% and 47% lower, respectively, and piperaquine AUC0-21d was 40% lower in pregnant women compared to nonpregnant women. DHA AUC0-8hr and piperaquine AUC0-21d were 27% and 38% lower, respectively, in pregnant women receiving efavirenz compared to HIV-uninfected pregnant women. Exposure to DHA and piperaquine were lower among pregnant women and particularly in women on efavirenz, suggesting a need for dose modifications. The study of modified dosing strategies for these populations is urgently needed., (© 2017 American Society for Clinical Pharmacology and Therapeutics.)- Published
- 2017
- Full Text
- View/download PDF
40. Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes.
- Author
-
de Rooij JD, Branstetter C, Ma J, Li Y, Walsh MP, Cheng J, Obulkasim A, Dang J, Easton J, Verboon LJ, Mulder HL, Zimmermann M, Koss C, Gupta P, Edmonson M, Rusch M, Lim JY, Reinhardt K, Pigazzi M, Song G, Yeoh AE, Shih LY, Liang DC, Halene S, Krause DS, Zhang J, Downing JR, Locatelli F, Reinhardt D, van den Heuvel-Eibrink MM, Zwaan CM, Fornerod M, and Gruber TA
- Subjects
- Animals, Exome genetics, Female, Gene Rearrangement genetics, Genomics methods, Humans, Mice, Mice, Inbred C57BL, Polymorphism, Single Nucleotide genetics, RNA genetics, Repressor Proteins genetics, Retinoblastoma-Binding Protein 2 genetics, Tumor Suppressor Proteins genetics, Down Syndrome genetics, Leukemia, Megakaryoblastic, Acute genetics
- Abstract
Acute megakaryoblastic leukemia (AMKL) is a subtype of acute myeloid leukemia (AML) in which cells morphologically resemble abnormal megakaryoblasts. While rare in adults, AMKL accounts for 4-15% of newly diagnosed childhood AML cases. AMKL in individuals without Down syndrome (non-DS-AMKL) is frequently associated with poor clinical outcomes. Previous efforts have identified chimeric oncogenes in a substantial number of non-DS-AMKL cases, including RBM15-MKL1, CBFA2T3-GLIS2, KMT2A gene rearrangements, and NUP98-KDM5A. However, the etiology of 30-40% of cases remains unknown. To better understand the genomic landscape of non-DS-AMKL, we performed RNA and exome sequencing on specimens from 99 patients (75 pediatric and 24 adult). We demonstrate that pediatric non-DS-AMKL is a heterogeneous malignancy that can be divided into seven subgroups with varying outcomes. These subgroups are characterized by chimeric oncogenes with cooperating mutations in epigenetic and kinase signaling genes. Overall, these data shed light on the etiology of AMKL and provide useful information for the tailoring of treatment.
- Published
- 2017
- Full Text
- View/download PDF
41. A multi-analyte panel for non-invasive pharmacokinetic monitoring of second-line anti-tuberculosis drugs.
- Author
-
Gerona R, Wen A, Koss C, Bacchetti P, Gandhi M, and Metcalfe J
- Subjects
- Antitubercular Agents administration & dosage, Antitubercular Agents blood, Chromatography, Liquid, Humans, Predictive Value of Tests, Reproducibility of Results, Spectrometry, Mass, Electrospray Ionization, Tandem Mass Spectrometry, Tuberculosis, Multidrug-Resistant blood, Tuberculosis, Multidrug-Resistant diagnosis, Tuberculosis, Multidrug-Resistant microbiology, Antitubercular Agents pharmacokinetics, Drug Monitoring methods, Drug Resistance, Multiple, Bacterial, Tuberculosis, Multidrug-Resistant drug therapy
- Published
- 2016
- Full Text
- View/download PDF
42. The expression of the peripheral cannabinoid receptor CB2 has no effect on clinical outcome in diffuse large B-cell lymphomas.
- Author
-
Rayman N, Lam KH, van der Holt B, Koss C, van Leeuwen J, Budel LM, Mulder AH, Sonneveld P, and Delwel R
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Algorithms, Biomarkers, Tumor metabolism, DNA-Binding Proteins metabolism, Disease-Free Survival, Female, Germinal Center metabolism, Humans, Immunohistochemistry, Interferon Regulatory Factors metabolism, Kaplan-Meier Estimate, Lymphoma, Large B-Cell, Diffuse classification, Lymphoma, Large B-Cell, Diffuse therapy, Male, Middle Aged, Neprilysin metabolism, Prognosis, Proto-Oncogene Proteins c-bcl-6, Retrospective Studies, Treatment Outcome, Young Adult, Lymphoma, Large B-Cell, Diffuse metabolism, Receptor, Cannabinoid, CB2 metabolism
- Abstract
Background: The peripheral cannabinoid receptor (CB2) is mainly detected on B cells in the germinal centers (GCs) of the immune system, using an antibody directed against the extra cellular N-terminal domain of the receptor. We retrospectively investigated the CB2 receptor expression in diffuse large B-cell lymphomas (DLBCL) and its clinical relevance for treatment outcome., Patients and Methods: We have constructed a tissue micro-array (TMA) using lymphoma tissue of a large cohort of patients with DLBCL (N = 104) who were treated with CHOP., Results: Forty-five out of 79 evaluable cases (57%) were CB2 positive. The expression of CB2 receptors was variably present in both the germinal center B cell (GCB) (n = 31) and the non-GCB/activated B-cell (ABC) (n = 43) DLBCL subtypes. CB2 positivity was not associated with a different outcome in this patient cohort (CR; P = 0.87, EFS; P = 0.32, DFS; P = 0.06 and OS; P = 0.18). Implementation of CB2 expression in the Hans algorithm using the markers CD10, BCL6, and MUM1 did not result in added prognostic value (all P-values >0.1)., Conclusions: We hypothesize that although CB2 is normally expressed in GCs, the expression in one of the malignant counterparts such as DLBCL is aberrant. This may be an explanation for the absence of prognostic relevance for the expression of this protein., (© 2011 John Wiley & Sons A/S.)
- Published
- 2011
- Full Text
- View/download PDF
43. Prognostic relevance of immunohistochemical subclassification of diffuse large B-cell lymphoma in two prospective phase III clinical trials.
- Author
-
Rayman N, Lam KH, van der Holt B, Koss C, Veldhuizen D, Budel LM, Mulder AH, Verdonck LF, Delwel R, de Jong D, van Imhoff GW, and Sonneveld P
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Cohort Studies, Female, Humans, Immunohistochemistry, Lymphoma, Large B-Cell, Diffuse metabolism, Lymphoma, Large B-Cell, Diffuse pathology, Male, Middle Aged, Prognosis, Prospective Studies, Young Adult, Lymphoma, Large B-Cell, Diffuse classification, Lymphoma, Large B-Cell, Diffuse drug therapy
- Abstract
Purpose: Until now molecular biologic techniques have not been easily used in daily clinical practice to stratify patients for therapeutic purposes. Therefore, we have investigated the prognostic relevance of the immunohistochemical (IHC) germinal center B-cell (GCB) versus non-GCB diffuse large B-cell lymphoma (DLBCL) subtypes., Patients and Methods: We have analyzed tumor samples from patients treated in 2 prospective multicenter phase III trials, ie HOVON 25 (patients≥65 years, n=153) and HOVON 26 (patients<65 years, n=144) using whole sections (WS) or tissue microarray (TMA). CD10, BCL6, and MUM1 were applied in a specific IHC algorithm. The effect on clinical outcome using WS or TMA and variations in cut-off levels of these markers was also investigated., Results: The GCB subtype was not associated with a better OS in either trial. Small differences were observed in the HOVON 25 trial between techniques, with TMA showing a better outcome for GCB than did WS. Variation of cut-off levels in the specific algorithm did not improve the prediction of clinical outcome., Conclusion: We did not observe a consistent predictive power of the GCB and non-GCB classification by IHC in this large series of DLBCL patients treated with CHOP. This underscores the need to determine the biologic variation and the standardization of the protein expression levels and to further study the relevance of prognostic IHC classifications, preferably in phase III clinical trials.
- Published
- 2011
- Full Text
- View/download PDF
44. Gender comparison of physiologic and perceptual responses in recreational marathon runners.
- Author
-
Loftin M, Sothern M, Tuuri G, Tompkins C, Koss C, and Bonis M
- Subjects
- Adult, Female, Humans, Male, Sex Distribution, Time Factors, Energy Metabolism physiology, Exercise Tolerance physiology, Perception physiology, Recreation physiology, Running physiology
- Abstract
Purpose: The aim of this investigation was to compare gender differences in physiologic and perceptual responses during a 1-h run at recent marathon pace and running economy at three speeds in recreational marathon runners., Methods: In a counterbalanced design, 10 men and 10 women completed a 1-h treadmill run and a running economy test. Treadmill speed for the 1-h run ranged from 141 to 241 mmin(-1) and 134, 168, and 188 m x min(-1) for running economy. Physiologic parameters (oxygen uptake, carbon dioxide production, pulmonary ventilation, and heart rate) and perceived exertion were measured. Repeated-measures ANOVA was used to compare any gender differences (P < .05) during the 1-h run and a two-way ANOVA was used to compare running economy. With this sample, estimated marathon energy expenditure, body composition, and maximal physiologic function was reported., Results: With the exception of an allometric expression of VO2 (mL x min(-1) kg BW(-0.75)), similar gender physiologic and perceptual responses were found during the 1-h run. Although not significant, the females exercised at a higher percent VO2(max) (8% to 9%) during the run. Similar gender differences were also noted during the running economy tests., Conclusions: Although the male runners completed a recent marathon significantly faster than the females, similar gender physiologic and perceptual responses were generally found during the 1-h treadmill run and the running economy tests.
- Published
- 2009
- Full Text
- View/download PDF
45. Gene expression profiling for improved dissection of acute leukemia: a recently identified immature myeloid/T-lymphoid subgroup as an example.
- Author
-
Wouters BJ, Koss C, and Delwel R
- Subjects
- CCAAT-Enhancer-Binding Proteins metabolism, Gene Expression Profiling, Gene Silencing, Humans, Mutation, Receptor, Notch1 genetics, Receptor, Notch1 metabolism, CCAAT-Enhancer-Binding Proteins genetics, Gene Expression Regulation, Leukemic, Leukemia, Myeloid, Acute genetics, Leukemia, Myeloid, Acute metabolism, Leukemia, T-Cell genetics, Leukemia, T-Cell metabolism
- Abstract
In this concise overview, we discuss recent findings concerning a distinct subgroup of acute myeloid/T-lymphoid leukemia. We describe how we identified these leukemias in multiple cohorts of acute myeloid leukemia (AML) using a combination of gene expression profiling and additional analytic approaches, and how we obtained insight in possible mechanisms leading to their phenotype.
- Published
- 2008
- Full Text
- View/download PDF
46. Generic entry, reformulations and promotion of SSRIs in the US.
- Author
-
Huskamp HA, Donohue JM, Koss C, Berndt ER, and Frank RG
- Subjects
- Chemistry, Pharmaceutical, Drug Approval, United States, Drug Industry economics, Drugs, Generic economics, Selective Serotonin Reuptake Inhibitors economics
- Abstract
Background: Previous research has shown that a manufacturer's promotional strategy for a brand name drug is typically affected by generic entry. However, little is known about how newer strategies to extend patent life, including product reformulation introduction or obtaining approval to market for additional clinical indications, influence promotion., Objective: To examine the relationships among promotional expenditures, generic entry, reformulation entry and new indication approval., Methods: We used quarterly data on national product-level promotional spending (including expenditures for physician detailing and direct-to-consumer advertising [DTCA], and the retail value of free samples distributed in physician offices) for selective serotonin reuptake inhibitors (SSRIs) over the period 1997-2004. We estimated econometric models of detailing, DTCA and total quarterly promotional expenditures as a function of the timing of generic entry, entry of new product formulations and US FDA approval for new clinical indications for existing medications in the SSRI class. Expenditures by pharmaceutical manufacturers for promotion of antidepressant medications was the main outcome measure., Results: Over the period 1997-2004, there was considerable variation in the composition of promotional expenditures across the SSRIs. Promotional expenditures for the original brand molecule decreased dramatically when a reformulation of the molecule was introduced. Promotional spending (both total and detailing alone) for a specific molecule was generally lower after generic entry than before, although the effect of generic entry on promotional spending appears to be closely linked with the choice of product reformulation strategy pursued by the manufacturer. Detailing expenditures for Paxil were increased after the manufacturer received FDA approval to market the drug for generalized anxiety disorder (GAD), while the likelihood of DTCA outlays for the drug was not changed. In contrast, FDA approval to market Paxil and Zoloft for social anxiety disorder (SAD) did not affect the manufacturers' detailing expenditures but did result in a greater likelihood of DTCA outlays., Conclusion: The introduction of new product formulations appears to be a common strategy for attempting to extend market exclusivity for medications facing impending generic entry. Manufacturers who introduced a reformulation before generic entry shifted most promotion dollars from the original brand to the reformulation long before generic entry, and in some cases manufacturers appeared to target a particular promotion type for a given indication. Given the significant impact that pharmaceutical promotion has on demand for prescription drugs in the US, these findings have important implications for prescription drug spending and public health.
- Published
- 2008
- Full Text
- View/download PDF
47. Energy expenditure and influence of physiologic factors during marathon running.
- Author
-
Loftin M, Sothern M, Koss C, Tuuri G, Vanvrancken C, Kontos A, and Bonis M
- Subjects
- Adult, Body Composition, Body Weight, Exercise physiology, Female, Heart Rate, Humans, Male, Oxygen Consumption, Regression Analysis, Sex Factors, Time Factors, Athletic Performance physiology, Energy Metabolism physiology, Running physiology
- Abstract
This study examined energy expenditure and physiologic determinants for marathon performance in recreational runners. Twenty recreational marathon runners participated (10 males aged 41 +/- 11.3 years, 10 females aged 42.7 +/- 11.7 years). Each subject completed a V(.-)O2max and a 1-hour treadmill run at recent marathon pace, and body composition was indirectly determined via dual energy X-ray absorptiometry. The male runners exhibited higher V(.-)O2max (ml x kg(-1) x min(-1)) values (52.6 +/- 5.5) than their female counterparts (41.9 +/- 6.6), although ventilatory threshold (T-vent) values were similar between groups (males: 76.2 +/- 6.1 % of V(.-)O2max, females: 75.1 +/- 5.1%). The male runners expended more energy (2,792 +/- 235 kcal) for their most recent marathon as calculated from the 1-hour treadmill run at marathon pace than the female runners (2,436 +/- 297 kcal). Body composition parameters correlated moderately to highly (r ranging from 0.50 to 0.87) with marathon run time. Also, V(.-)O2max (r = -0.73) and ventilatory threshold (r = -0.73) moderately correlated with marathon run time. As a group, the participants ran near their ventilatory threshold for their most recent marathon (r = 0.74). These results indicate the influence of body size on marathon run performance. In general, the larger male and female runners ran slower and expended more kilocalories than smaller runners. Regardless of marathon finishing time, the runners maintained a pace near their T-vent, and as T-vent or V(.-)O2max increased, marathon performance time decreased.
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.